Watch for Interactions Between Amiodarone and Hep C Meds

June 2015

You'll hear reports of a potentially dangerous interaction between amiodarone and the new hep C drug, sofosbuvir (Sovaldi, Harvoni).

Combining amiodarone with sofosbuvir-containing hep C regimens may lead to serious bradycardia, cardiac arrest, and pacemaker placement.

Patients seem to be at higher risk for bradycardia if they are also on a beta-blocker or have cardiovascular or liver disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote